EI
KRYS icon

EFG International’s Krystal Biotech KRYS Stock Holding History

EFG International’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.69M Sell
15,304
-4,745
-24% -$1.42M 0.1% 167
2026
Q1 		$5.18M Sell
20,049
-3,520
-15% -$937K 0.11% 170
2025
Q4 		$5.82M Buy
+23,569
New +$4.96M 0.11% 152

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

EFG International's KRYS Position: Q2 2026 in Review

EFG International reduced its Krystal Biotech (KRYS) stake by 24% in Q2 2026, selling an estimated $1.42M and leaving 15,304 shares worth $5.69M. The position accounts for 0.1% of the portfolio, ranked #167.

EFG International first reported a position in KRYS in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.82M in Q4 2025. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • EFG International held 15,304 shares of Krystal Biotech worth $5.69M as of Q2 2026.
  • EFG International sold 4,745 Krystal Biotech shares in Q2 2026, an estimated $1.42M.
  • Krystal Biotech made up 0.1% of EFG International's portfolio in Q2 2026, its #167 holding.
  • EFG International first reported a position in Krystal Biotech in Q4 2025 and has held it in 3 quarters since.
  • EFG International's Krystal Biotech position peaked at $5.82M in Q4 2025.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on EFG International's 13F filing for Q2 2026, filed 14 Aug 2026.